|
2023
|
Invention
|
Niraparib compositions.
The present invention relates to compositions comprising the compound ni... |
|
|
Invention
|
Tablet formulation for cgrp active compounds.
The present invention is directed to compositions ... |
|
|
Invention
|
Method of treating acute migraine with cgrp-active compound.
A method of alleviating or mitigati... |
|
|
Invention
|
Treatment of metastatic pancreatic adenocarcinoma.
A method of treating metastatic pancreatic ad... |
|
2022
|
Invention
|
Small molecule inhibitors of kras g12c mutant. Compounds of Formula (I) or their pharmaceutically... |
|
|
Invention
|
Methods for treating cancer with a wee1 inhibitor.
The present invention relates generally to th... |
|
|
Invention
|
Small molecule inhibitors of kras g12c mutant. Compounds of Formula (I) or (la) or their pharmace... |
|
|
Invention
|
Small molecule inhibitors of kras g12c mutant. Compounds or their pharmaceutically acceptable sal... |
|
|
Invention
|
Small molecule inhibitors of kras g12d mutant. Compounds or their pharmaceutically acceptable sal... |
|
2021
|
Invention
|
Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesviruses... |
|
|
Invention
|
Il-2 muteins for treating autoimmune and inflammatory diseases. Provided herein are IL-2 muteins ... |
|
|
Invention
|
Preparation of tetrahydroindazole derivatives as novel diacylglyceride o-acyltransferase 2 inhibi... |
|
|
Invention
|
Synthesis of antiviral nucleosides. The present invention relates to efficient synthetic processe... |
|
|
G/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals |
|
|
Invention
|
Enterovirus purification with cation exchange chromatography. The present invention relates to a ... |
|
|
Invention
|
Fused bicyclic pyrazole derivatives and methods of use thereof for the treatment of herpesviruses... |
|
|
Invention
|
Syringes and injectors with capacitive sensing and methods of making and using same. An injecting... |
|
|
Invention
|
Mini-tablet dosage form of a viral terminase inhibitor and uses thereof. The present invention re... |
|
|
Invention
|
Urea orexin receptor agonists. The present invention is directed to urea compounds which are agon... |
|
|
Invention
|
S-methylthioribose kinase polypeptides and processes for making and using s-methylthioribose kina... |
|
|
Invention
|
Aseptic manifold dispensing assembly. An aseptic manifold dispensing assembly that comprises a co... |
|
|
Invention
|
Fused [7,5] bicyclic pyrazole derivatives and methods of use thereof for the treatment of herpesv... |
|
|
Invention
|
Tetrahydroquinazoline derivatives as selective cytotoxic agents. The present disclosure is direct... |
|
|
Invention
|
Compact containment system for isolating, processing and packaging pharmaceutical products. A com... |
|
|
Invention
|
Apparatus and method for collecting dried pharmaceutical product from a pharmaceutical drying dev... |
|
|
Invention
|
3-heteroaryl pyrrolidine and piperidine orexin receptor agonists. The present invention is direct... |
|
|
Invention
|
Chemistry, manufacturing, and controls change assessment system. A user (e.g., a CMC scientist) i... |
|
|
Invention
|
6,7-dihydro-pyrano[2,3-d]pyrimidine inhibitors of kras g12c mutant.
The disclosure provides comp... |
|
|
Invention
|
6,7-dihydro-pyrano[2,3-d]pyrimidine inhibitors of kras g12c mutant. The disclosure provides compo... |
|
|
Invention
|
Spirocyclic-substituted 6,7-dihydro-pyrano[2,3-d]pyrimidine inhibitors of kras g12c mutant. The d... |
|
|
Invention
|
Arginase 1 binders for inhibiting arginase 1 activity. Arginase 1 binders that inhibit the activi... |
|
|
Invention
|
Arginase 1 binders for inhibiting arginase 1 activity. Arginase 1 binders that inhibit activity o... |
|
|
Invention
|
Arginase 1 binders for inhibiting arginase 1 activity. Arginase 1 binders comprising human antibo... |
|
|
Invention
|
Modified isoindolinones as glucosylceramide synthase inhibitors. The present invention relates to... |
|
|
Invention
|
Saccharomyces cerevisiae. Saccharomyces cerevisiaeS. cerevisiaeS. cerevisiae host cell, wherein t... |
|
|
Invention
|
Nav1.7 binders. Antibodies and antigen-binding fragments thereof that bind the human voltage-gate... |
|
|
Invention
|
3-amino pyrrolidine and piperidine macrocyclic orexin receptor agonists. The present invention is... |
|
|
Invention
|
Plasma kallikrein inhibitors. The present invention provides a compound of Formula (I) and pharma... |
|
|
Invention
|
Increased voltage-gated sodium channel alpha protein subunit expression through viral 2a-mediated... |
|
|
Invention
|
Anti-respiratory syncytial virus (rsv) antibody cell-based potency assay. The disclosure describe... |
|
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
|
Invention
|
Automated biomanufacturing systems, facilities, and processes.
Disclosed are a process and an au... |
|
|
Invention
|
Aryl sulfonamides as blt1 antagonists.
Novel compounds of the structural formula (I), and the ph... |
|
|
Invention
|
Il4i1 inhibitors and methods of use. Described herein are compounds of Formula I or a pharmaceuti... |
|
|
Invention
|
Methods and reagents for synthesizing nucleosides and analogues thereof.
The present invention r... |
|
|
G/S
|
Pharmaceutical preparations |
|
2020
|
Invention
|
Combination of a pd-1 antagonist, a vegfr/fgfr/ret tyrosine kinase inhibitor and a cbp/beta-caten... |
|
|
Invention
|
Methods and compositions comprising an anti-ctla4 monoclonal antibody with reduced host cell pro... |
|
|
Invention
|
Drug delivery system for the delivery of antiviral agents.
This invention relates to novel impla... |
|
|
Invention
|
Methods of treating patients with an immunogenic composition that protects against s. pneumoniae ... |
|
2019
|
Invention
|
Prmt5 inhibitors.
The present invention provides a compound of Formula (I) and the pharmaceutica... |
|
2017
|
G/S
|
Pharmaceutical preparations for human use for the prevention and treatment of allergies, cardiova... |
|
|
G/S
|
Printed material, namely, advertisements namely posters, pamphlets and cardboard signs, newslette... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of diabetes, cardiovascular diseases and disorders,... |
|
2016
|
G/S
|
Pharmaceutical preparations for the treatment of neurological diseases and disorders namely, Alzh... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disor... |
|
2015
|
G/S
|
Pharmaceutical preparations for human use in oncology |
|
2014
|
G/S
|
Pharmaceutical preparations for the treatment of autoimmune diseases and disorders. |
